From Months to Minutes: AI-Driven Ingredient Intelligence Revolutionizing OTC Drug Discovery

After facing costly delays and fragmented research cycles, a leading pharmaceutical company partnered with us to build a next-generation ingredient discovery platform designed to streamline OTC (Over the Counter) drug development. The company had a clear business vision: to transform drug sourcing and formulation by targeting underutilized, low-risk ingredients. The objective was to identify safe, underutilized drug ingredients through market, clinical, and regulatory intelligence. Our team at NextGen Invent collaborated closely to architect and develop the platform, equipped with AI-powered classification models, automated data pipelines, and centralized dashboards. This platform unified disparate sources, from FDA regulatory datasets to market activity monitors, into a single, cohesive intelligence hub.

Today, this solution has helped our client slash R&D timelines, gain a competitive advantage in ingredient sourcing, and rapidly expand their product pipeline into OTC pharmaceuticals.

The client is a transformative pharmaceutical company with a mission to enhance patient care by delivering affordable, high-value medications addressing unmet clinical needs. They specialize in identifying and commercializing safe, effective pharmaceutical products by leveraging business intelligence and data-driven product discovery methods. With a unique market approach focused on reducing regulatory friction, the company seeks to optimize OTC drug formulation by targeting well-established yet underutilized ingredients.

90 Mins Reduced Screening Time ↓

24x Faster Increased Screening Speed ↑

Industry

Life Sciences (Pharmaceutical Manufacturing)

Business Problem

Fragmented Data Ecosystem: Teams had to manually extract and cross-verify ingredient information across multiple unconnected sources, including the FDA, the FDA Orange Book, AnalySource, clinical trial data, trademark repositories, and market activity trackers, leading to lengthy and error-prone research cycles.

Time-Intensive Ingredient Identification: The absence of intelligent automation resulted in R&D teams spending 3–4 months manually validating potential drug ingredients across regulatory, clinical, and market datasets, creating bottlenecks in screening speed and stalling product pipeline growth.

Inconsistent Regulatory Classification: With no automated system to differentiate between OTC and prescription statuses, teams faced frequent classification errors, extended manual reviews, and regulatory uncertainty, slowing down ingredient approvals and increasing risks during product development.

Missed Market Opportunities: Without proactive identification of “orphan” drugs (ingredients with limited market presence), the company struggled to identify underutilized, low-competition ingredients, resulting in missed chances to rapidly commercialize unique, high-value OTC products with minimal market competition.

High Risk of Trademark Conflicts: Manual verification processes to check ingredient-related trademark availability were cumbersome and increased the risk of conflicts at late stages of product commercialization.

Solution Approach

Unified Ingredient Intelligence Platform: We engineered a robust platform that consolidates and analyzes data from the FDA Orange Book, DrugBank, USPTO trademark databases, Analysource, and other regulatory sources, providing a single point of truth for ingredient research and selection.

Off-Label & OTC Classification AI Model: Developed and deployed AI-powered classification models that automatically distinguish between prescription and OTC drugs, including off-label use indicators, enabling rapid decision-making on formulation pathways.

Automated Orphan Ingredient Discovery: Created automated pipelines connecting Analysource and market sales datasets to instantly identify orphan ingredients, uncovering low-competition, high-opportunity candidates, and accelerating their evaluation for rapid entry into the OTC drug market.

Trademark Conflict Detection: Deployed automated USPTO data pipelines that continuously monitor for trademark ownership conflicts, empowering early-stage identification of legal risks, preventing costly product reworks, and safeguarding commercialization processes from late-stage disruptions.

End-to-End Dashboard for Ingredient Profiling: Designed an intuitive, real-time dashboard combining regulatory status, market trends, clinical validation, and trademark insights, replacing fragmented data access with centralized, actionable intelligence for faster, informed product development decisions.

Book a Free Consultation

Value Delivered

Our end-to-end ingredient intelligence solution transformed the client’s OTC drug development lifecycle, reducing ingredient screening time from 3–4 months to just 90 minutes. The centralized platform eliminated manual data hunting, minimized human error, and unlocked unprecedented agility in bringing OTC formulations to market.

With AI-powered classification and automated market analysis, the company now confidently identifies low-risk, high-potential ingredients faster than ever, accelerating R&D and reducing time-to-market. Seamless access to regulatory, clinical, and commercial intelligence ensures informed decisions, enabling pipeline expansion with reduced overhead. By replacing fragmented workflows with a cohesive ingredient discovery engine, we empowered the client to build a scalable, data-backed approach to OTC drug development, setting new benchmarks in pharmaceutical innovation speed and efficiency.

Our Case Study

Gen AI-Driven Decision Engine brings Innovations to Consumer Product Testing

The capacity to identify potential safety hazards and address them before they become issues is another significant advantage of predictive maintenance in fleet management. To determine what might go wrong, they look at data on historical accidents, driver behavior, and vehicle performance.

→

How Fleets Can Maximize Uptime and Efficiency with Predictive Maintenance?

Maintaining cost-effectiveness and operational efficiency is crucial in the cutthroat field of fleet management. Predictive maintenance has become a game-changing strategy among the numerous others that are accessible. Predictive maintenance has been shown to, boost vehicle availability by 20% , lower maintenance costs by up to 25%

→

How AI in Inventory Management is Redefining Inventory Control?

Modern businesses rely heavily on inventory, which is also may be their most important asset. It can have an impact on consumer satisfaction, turnaround time, sales, production, and even profitability. Therefore, a key component of supply chain management and one of the main objectives of enterprises is the efficient use of AI in inventory management.

→

Gen AI-Driven Decision Engine brings Innovations to Consumer Product Testing

However, 43% of small businesses do not keep an eye on their inventory, and only 6% of companies say they have complete supply chain visibility, which is necessary for efficient inventory management. As global inventory management in supply chain management networks becomes more complex and the need for disruption-immune operations becomes more pressing.

→